Contracts Finder · Award
Short Course in Genome Sequencing
A public procurement published by Health Education England via Contracts Finder.
- £970k
- Award value
- £485k
- Tender value
- 1
- Suppliers
- 2
- Awards
- 2
- Notices
- Award
- Stage
Overview
a short course on Whole Genome Sequencing (WGS), for both senior clinicians and scientists to be developed and piloted.
Key details
- Source
- Contracts Finder
- Lifecycle stage
- Award
- Status
- complete
- CPV classification
- 80000000 — Education and training services
- Currency
- GBP
- Total award value
- £970,000
- Tender value
- £485,000
- First published
- 26 May 2022
- Last updated
- 25 Apr 2023
Awards
2 awards recorded on this procurement.
| Supplier | Companies House | Awarded | Status | Value |
|---|---|---|---|---|
| The Association for Clinical Biochemistry and Laboratory Medicin | — | 25 May 2022 | active | £485k |
| The Association for Clinical Biochemistry and Laboratory Medicin | — | 25 May 2022 | active | £485k |
Notice timeline
Every published notice in this procurement's lifecycle.
All suppliers
Frameworks & programmes
More from Health Education England
FAQs about this procurement
Who is the buyer for "Short Course in Genome Sequencing"?
Short Course in Genome Sequencing is a UK public-sector procurement published by Health Education England via Contracts Finder.
Has "Short Course in Genome Sequencing" been awarded?
Yes — 2 awards are recorded, with a reported total value of £970,000. The current lifecycle stage is "Award".
Which suppliers are involved in "Short Course in Genome Sequencing"?
1 supplier is linked: The Association for Clinical Biochemistry and Laboratory Medicin.
What is "Short Course in Genome Sequencing" worth?
The reported award value is £970,000.
When was "Short Course in Genome Sequencing" published?
It was first published on 26 May 2022 and last updated on 25 Apr 2023, across 2 notices.
Track procurements like this one
Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.
Get in touch with Enable